We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,236.00
Bid: 2,236.00
Ask: 2,238.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.089%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,236.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

11 Feb 2016 07:00

RNS Number : 7060O
Halma PLC
11 February 2016
 

Halma plc

 

Trading Update

 

11 February 2016

 

 

 

Halma, the leading safety, health and environmental technology group today releases a Trading Update covering the period from 4th October 2015 to date.

 

Based on current trading and forecasts, the Board expects adjusted profit before tax for the year ending 2 April 2016 to be in line with market expectations (see notes 1 and 2). The group continues to benefit from the diversity of its markets and resilient growth drivers. Order intake has remained ahead of revenue.

 

Halma's four sectors have traded in line with the broad pattern established in the first half of the financial year. The Infrastructure Safety, Medical and Environmental & Analysis sectors have all made good progress. Process Safety has continued to have weakening demand from its Oil & Gas related customers, only partially offset by growth in other markets.

 

Organic constant currency revenue growth has continued in the second half. The USA has maintained a strong performance. Mainland Europe, the UK and Asia Pacific are making steady progress. In other regions there has been continued weakness in South America and good growth in Near and Middle East.

 

We continue to be committed to increased investment to drive organic growth and to finding acquisition opportunities which meet our strategic and financial criteria. During the period we completed three acquisitions, which have all traded in-line with expectations.

 

· In October 2015, Halma announced the acquisition of Firetrace USA for $110 million (£72.8 million) adding fire suppression technologies to our fire detection businesses within the Infrastructure Safety sector.

 

· In December 2015, Halma announced the acquisition of Visiometrics for an initial consideration of €18 million (£13.1 million) and deferred contingent consideration of up to €107 million (£78.1 million) based on performance over the next 5 years. Visiometrics adds new eyesight measurement and diagnostic technology to our ophthalmic device businesses within the Medical sector.

 

· On 5 February 2016, Halma announced the acquisition of CenTrak, which makes products that provide real-time monitoring of resources and activity within healthcare facilities. The consideration paid was $140 million (£95.9 million) and Centrak is now part of our Medical sector.

 

The Group's financial position is strong. In January 2016, we completed a US Private Placement totalling $250 million providing additional capacity to our existing syndicated bank facility of £360 million.

 

The results for the year ending 2 April 2016 are expected to be released on 14 June 2016.

 

 

Conference call

 

Andrew Williams (Chief Executive) and Kevin Thompson (Finance Director) will host a conference call for analysts and investors on this announcement at 8.00am (UK time) today (11 February). To join the call, please use the dial-in numbers below:

 

Dial: +44 (0) 1452 555 566

PIN: 49673588

 

 

For further information, please contact:

 

Halma plc Tel: +44 (0)1494 721111

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

MHP Communications Tel: +44 (0)20 3128 8100

Rachel Hirst/Andrew Jaques

 

 

Notes:

 

1.

Adjusted profit before tax is before amortisation of acquired intangible assets, acquisition items and profit or loss on disposal of operations.

 

2.

The Board believes current market forecasts for adjusted profit before tax to be in the range of £161.6 million to £171.5 million with a consensus of £164.8 million.

 

3.

This Trading Update is based on unaudited management accounts information and has been prepared solely to provide additional information to the shareholders of Halma plc. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

4.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFWFMSFMSEFE
Date   Source Headline
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.